Grail's Galleri Blood Test Fails Primary Endpoint in 142,000-Patient NHS Trial — Company Pivots to Secondary Data

Grail's Galleri Blood Test Fails Primary Endpoint in 142,000-Patient NHS Trial — Company Pivots to Secondary Data | BedrockNews